Transplant Immunology
Scope & Guideline
Enhancing Understanding Through Cutting-edge Research.
Introduction
Aims and Scopes
- Transplant Rejection Mechanisms:
The journal explores the cellular and molecular mechanisms underlying both acute and chronic rejection in solid organ and hematopoietic stem cell transplants, providing insights into immune responses and their modulation. - Immunosuppressive Strategies:
Research on various immunosuppressive regimens, including the efficacy and safety of novel agents, is a core focus. The journal evaluates the impact of these therapies on transplant outcomes and patient survival. - Infection and Immunity:
The relationship between infections, particularly viral infections like CMV and COVID-19, and their effects on transplant recipients' immune response is a significant area of investigation. - Biomarkers and Diagnostics:
The identification and validation of biomarkers for predicting transplant outcomes, rejection, and complications are emphasized, aiding in the development of personalized medicine approaches. - Cell Therapy and Regenerative Medicine:
The application of stem cell therapies and regenerative medicine techniques in improving transplant outcomes and managing rejection is increasingly featured in the journal. - Ethical and Societal Issues in Transplantation:
The journal also addresses ethical considerations and societal impacts of organ transplantation, including donor-recipient matching, allocation policies, and public perceptions.
Trending and Emerging
- COVID-19 and Transplantation:
The impact of COVID-19 on transplant recipients, including vaccination responses and infection management, has become a prominent theme, reflecting the pandemic's influence on healthcare. - Machine Learning and Bioinformatics:
The integration of machine learning and bioinformatics in predicting transplant outcomes and personalizing immunosuppressive therapy is gaining traction, indicating a shift towards data-driven approaches in transplantation. - Microbiome and Immune Interactions:
Research exploring the role of the gut microbiome in modulating immune responses in transplant recipients is emerging, highlighting the importance of microbial health in transplantation. - Cell-Based Therapies:
The use of cell-based therapies, particularly involving mesenchymal stem cells and regulatory T cells, is increasingly featured, indicating a growing interest in regenerative approaches to manage rejection. - Longitudinal Studies and Real-World Data:
There is a rising emphasis on longitudinal studies and the use of real-world data to assess long-term outcomes and complications post-transplantation, providing a more comprehensive understanding of transplant success.
Declining or Waning
- Traditional Immunosuppressive Agents:
Research focusing solely on traditional immunosuppressive agents like calcineurin inhibitors has seen a decline as newer, more targeted therapies gain interest and application in clinical settings. - Generalized Risk Factors for Rejection:
While risk factors for transplant rejection remain important, the focus has shifted towards more specific biomarkers and mechanistic studies rather than broad, generalized factors. - Descriptive Case Reports:
While case reports are valuable, there is a noticeable decrease in the publication of purely descriptive case reports, with a preference for studies that provide mechanistic insights or larger cohort analyses.
Similar Journals
TRANSPLANT INTERNATIONAL
Championing Open Access for Global Transplant SolutionsTRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.
OncoImmunology
Advancing Cancer Care Through Immune InsightsOncoImmunology is a leading peer-reviewed journal published by Taylor & Francis Inc, dedicated to advancing the understanding of the dynamic interplay between the immune system and cancer. Established in 2012 and adopting an open access model since 2020, OncoImmunology provides a platform for high-quality research disseminated globally, with a notable focus on innovative therapies and immunotherapeutic strategies aimed at improving patient outcomes. The journal boasts an impressive impact in the field, holding Q1 rankings in both Immunology and Oncology categories for 2023, and it is recognized within the top-tier journals in its domain, reflected in its Scopus ranks and percentiles. With contributions from leading experts and a wide audience of researchers, clinicians, and advanced students, OncoImmunology not only facilitates scholarly dialogue but also addresses pivotal challenges in cancer treatment, making it an essential resource for those invested in the future of oncological and immunological research.
Transplantation Direct
Pioneering Open Access Solutions in Transplantation ScienceTransplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.
Journal of Transplantation
Advancing the Frontiers of Organ TransplantationThe Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.
Transplantation Reviews
Transforming challenges into solutions in transplantation.Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
Advancing kidney health and blood pressure insights.CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and research in the fields of nephrology and hypertension. Since its inception in 1992, this journal has been an essential resource for professionals seeking to stay at the forefront of kidney health and blood pressure management. With a distinguished ranking in the top quartile (Q1) for both Internal Medicine and Nephrology as of 2023, the journal is recognized for its high impact, currently holding a Scopus rank of #16 out of 81 in Nephrology, positioning it in the 80th percentile. Although not an open access journal, it provides crucial insights and expert opinions that cater to researchers, clinicians, and students committed to improving patient outcomes through evidence-based practice. The journal continues to emphasize its objectives of disseminating pivotal findings and fostering discussions that bridge the gap between clinical practice and research, making it an invaluable asset in the evolving landscape of nephrology and hypertension.
Indian Journal of Transplantation
Advancing Transplantation Knowledge GloballyIndian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.
CURRENT OPINION IN IMMUNOLOGY
Leading the Charge in Immunology InsightsCURRENT OPINION IN IMMUNOLOGY is a prestigious journal dedicated to the dynamic field of immunology, published by CURRENT BIOLOGY LTD in the United Kingdom. With an ISSN of 0952-7915 and an E-ISSN of 1879-0372, this journal has been a cornerstone of scholarly communication since its inception in 1988 and continues to disseminate cutting-edge research and reviews aimed at advancing our understanding of immune responses. Holding a remarkable Q1 ranking in both Immunology and Allergy categories for 2023, it ranks impressively within the top percentiles in its field, securing 27th233 in Immunology and Allergy and 31st out of 236 in Immunology and Microbiology. Emphasizing high-impact research, the journal provides researchers, professionals, and students with valuable insights into emerging trends and critical developments. As a vital resource in immunological research, it serves as a platform for disseminating innovative findings, fostering collaboration, and enhancing scholarly exchange in a rapidly evolving scientific landscape.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
Unveiling New Horizons in Cardiovascular and Pulmonary MedicineJOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.
Current Opinion in Organ Transplantation
Leading the Dialogue in Organ Transplant ResearchCurrent Opinion in Organ Transplantation, published by Lippincott Williams & Wilkins, serves as a leading journal in the fields of immunology and transplantation, providing insightful reviews and expert opinions that shape the discourse in these vital areas of medical research. With an impact factor showcasing its significance and influence in the academic community, this journal is ranked in the Q2 category for both Immunology and Transplantation according to the 2023 metrics, affirming its essential role in advancing knowledge and understanding. Spanning from its inception in 2001 through to 2024, Current Opinion in Organ Transplantation offers a platform for researchers, professionals, and students to engage with the latest advancements and trends, contributing to the ongoing dialogue that drives innovation in organ transplantation and immunological therapies. Although the journal does not currently offer open access options, its rigorous peer-review process and reputable publisher ensure the highest quality of research dissemination, making it an invaluable resource for those invested in the future of organ transplantation.